HIV :: First large-scale HIV vaccine trial in South Africa opens
A large-scale clinical trial of a candidate HIV vaccine?which previously showed promise in smaller studies in the United States and elsewhere?has now opened in South Africa.
A large-scale clinical trial of a candidate HIV vaccine?which previously showed promise in smaller studies in the United States and elsewhere?has now opened in South Africa.
Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine to protect women against contracting the most common sexually-transmitted disease, chlamydia.
CRNS and the Institut Pasteur conducted research in France on patients diagnosed with cryptococcosis which ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed.
Every year, more than a thousand college students die by suicide, and thousands more attempt to kill themselves.
Type II bipolar disorder is an underdiagnosed disease which can be easily confused with depression.
According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.
Lower transplant rates in ethnic communities may be explained somewhat by a lack of suitable anonymous donors, a problem the medical community has long known and been working to address.
Researchers at the 27th Annual Society for Maternal-Fetal Medicine (SMFM) meeting announced today that high-dose progesterone treatment helped at-risk pregnant women avoid premature delivery.
There is accumulating data that suggests in addition to directly killing tumor cells, reoviruses may prime the immune system to mount a separate, powerful and long lasting defense against cancer.
A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes – as well as treat other health problems.